TARGET
saveHER2
HER2/neu receptor; breast and gastric cancer target.
also known as: erbb2, her-2, neu
🐶 often sniffed alongside
top 8- tagOncology48 co-mentions · 8 sources
- tagBreast Cancer47 co-mentions · 8 sources
- tagAdCom19 co-mentions · 16 sources
- tag510(k) Clearance10 co-mentions · 10 sources
- tagPMA Approval8 co-mentions · 5 sources
- tagMonoclonal Antibody6 co-mentions · 3 sources
- drugpertuzumab + trastuzumab2 co-mentions · 1 sources
- drugpertuzumab2 co-mentions · 1 sources
drugs
0
catalysts
0
news
734
companies
0
Top drugs
no drugs tagged with this interest yet
🐶 Top companies
no companies tagged with this interest yet
Recent catalysts
no catalysts tagged with this interest yet
Recent news
view all →- Moderna, Neurocrine bring back familiar faces; Pharming CEO exits after clashing with boardendpoints · 2d ago
- 2026 IPO blitz continues with 4 new biotech filingsbiospace · 12d ago
- An orexin drug’s ‘proof-of-concept’ in ADHD; Cue’s ‘unwarranted’ share slidebiopharma dive · 12d ago
- Iambic maintains momentum from string of Big Pharma partnerships by aiming for IPOfiercebiotech · 13d ago
- STAT+: England to cover AstraZeneca breast cancer drug, a result of U.K.-U.S. drug pricing dealstat · 17d ago
- WCLC ‘26: A new ‘ADC era,’ China questions and AstraZeneca’s spotlightbiopharma dive · 19d ago
- AstraZeneca’s newly approved pill fails frontline breast cancer studybiopharma dive · 20d ago
- AstraZeneca’s newly approved cancer pill fails late-stage study, blocking path to bigger marketbiospace · 20d ago
Data sources
last refreshed 1h ago
Found something off?
comments(0)
5-min edit window · permanent after that